Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.31 |
| ▸ | PDE2A | O00408 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25824754 | 0.86 | CCR1 (0.33) | CCR1RAB9ACCR5 | |
| SCHEMBL26008003 | 0.77 | PDE10A (0.34) | PSMB5PDK2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL29324261 | 0.76 | CCR1 (0.48) | CCR1RAB9ACCR5MEN1KMT2A | |
| SCHEMBL22925185 | 0.74 | CAMKK2 (0.36) | CCR1RAB9ACCR5CAMKK2PSMB5 | |
| SCHEMBL22925158 | 0.73 | CAMKK2 (0.35) | CCR1RAB9ACCR5CAMKK2PSMB5 | |
| SCHEMBL24335376 | 0.73 | CCR1 (0.45) | CCR1RAB9ACCR5MEN1KMT2A | |
| SCHEMBL25312907 | 0.72 | METAP2 (0.47) | CCR1RAB9ACCR5MEN1KMT2A | |
| SCHEMBL28478012 | 0.71 | CYP2D6 (0.42) | PSMB5CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL26007879 | 0.70 | PSMB5 (0.33) | PSMB5CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL26566969 | 0.70 | ALDH1A1 (0.41) | PSMB5CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685754-B2 | Heteroleptic organic electroluminescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685754-B2 | Heteroleptic organic electroluminescent materials | IK, ORC3, CACNA2D2 | CCR1 2845/4885RAB9A 580/4885CCR5 1794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.